{"id":46001,"date":"2026-02-19T03:16:05","date_gmt":"2026-02-19T03:16:05","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/adult-malignant-glioma-therapeutics-market-mordor\/"},"modified":"2026-09-25T04:59:22","modified_gmt":"2026-09-24T19:59:22","slug":"adult-malignant-glioma-therapeutics-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/adult-malignant-glioma-therapeutics-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc131\uc778 \uc545\uc131 \uc2e0\uacbd\uad50\uc885 \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d \u2013 \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/adult-malignant-glioma-therapeutics-market_1676613218057_Picture2.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/adult-malignant-glioma-therapeutics-market-size-image-1770813299736.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud604\ud669<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc545\uc131 \uc2e0\uacbd\uad50\uc885 \ubc1c\ubcd1\ub960 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \uacf5\uacf5 \ubd80\ubb38 R&amp;D \uc790\uae08 \uc9c0\uc6d0 \uc9c0\uc18d<\/li>\n<li class=\"toc-level-3\">4.2.3 \uc2e0\uaddc \uae30\uae30\uc5d0 \ub300\ud55c \uc2e0\uc18d \uc2ec\uc0ac \ubc0f \ud601\uc2e0 \uc758\ub8cc\uae30\uae30 \uc9c0\uc815<\/li>\n<li class=\"toc-level-3\">4.2.4 AI \uae30\ubc18 \uc870\uae30 \uc9c4\ub2e8 \ubc0f \uce58\ub8cc \uacc4\ud68d<\/li>\n<li class=\"toc-level-3\">4.2.5 BNCT \ud50c\ub7ab\ud3fc\uc73c\ub85c \ubca4\ucc98 \uce90\ud53c\ud0c8 \uc720\uc785 \uae09\uc99d<\/li>\n<li class=\"toc-level-3\">4.2.6 \ubca0\ubc14\uc2dc\uc8fc\ub9d9 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\uc758 \uac00\uc6a9\uc131<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \ub0ae\uc740 \ud6c4\uae30 \uc784\uc0c1 \uc2dc\ud5d8 \uc131\uacf5\ub960<\/li>\n<li class=\"toc-level-3\">4.3.2 \ud14c\ubaa8\uc878\ub85c\ub9c8\uc774\ub4dc \ub0b4\uc131\uc758 \ube60\ub978 \ucd9c\ud604<\/li>\n<li class=\"toc-level-3\">4.3.3 \ubd95\uc18c-10 \ub3d9\uc704\uc6d0\uc18c \uacf5\uae09\ub9dd \ubcd1\ubaa9 \ud604\uc0c1<\/li>\n<li class=\"toc-level-3\">4.3.4 \uc885\uc591\ud559 R&amp;D \uc790\ubcf8\uc774 \ubc1c\uc0dd\ub960\uc774 \ub192\uc740 \uc885\uc591\uc73c\ub85c \uc804\ud658<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.5 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.5.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.5.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.5.3 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.5.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.5.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (USD \uac00\uce58)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc9c8\ubcd1 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \uad50\ubaa8\uc138\ud3ec\uc885<\/li>\n<li class=\"toc-level-3\">5.1.2 \uc5ed\ud615\uc131 \uc131\uc0c1\uc138\ud3ec\uc885<\/li>\n<li class=\"toc-level-3\">5.1.3 \uc5ed\ud615\uc131 \ud76c\uc18c\ub3cc\uae30\uc544\uad50\uc885<\/li>\n<li class=\"toc-level-3\">5.1.4 \uc5ed\ud615\uc131 \ud76c\uc18c\uc131\uc0c1\uc138\ud3ec\uc885<\/li>\n<li class=\"toc-level-3\">5.1.5 \uae30\ud0c0 \uace0\ub4f1\uae09 \uc2e0\uacbd\uad50\uc885<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uce58\ub8cc\ubc95\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \ud654\ud559\uc694\ubc95<\/li>\n<li class=\"toc-level-4\">5.2.1.1 \ud14c\ubaa8\uc878\ub85c\ub9c8\uc774\ub4dc<\/li>\n<li class=\"toc-level-4\">5.2.1.2 \ub85c\ubb34\uc2a4\ud2f4<\/li>\n<li class=\"toc-level-4\">5.2.1.3 \uce74\ub974\ubb34\uc2a4\ud2f4<\/li>\n<li class=\"toc-level-4\">5.2.1.4 \ubca0\ubc14\uc2dc\uc8fc\ub9d9<\/li>\n<li class=\"toc-level-4\">5.2.1.5 \uae30\ud0c0 \uc54c\ud0ac\ud654\uc81c<\/li>\n<li class=\"toc-level-3\">5.2.2 \ud45c\uc801 \uce58\ub8cc<\/li>\n<li class=\"toc-level-4\">5.2.2.1 EGFR \uc5b5\uc81c\uc81c<\/li>\n<li class=\"toc-level-4\">5.2.2.2 VEGF\/VEGFR \uc5b5\uc81c\uc81c<\/li>\n<li class=\"toc-level-4\">5.2.2.3 IDH \uc5b5\uc81c\uc81c<\/li>\n<li class=\"toc-level-3\">5.2.3 \uba74\uc5ed\uc694\ubc95<\/li>\n<li class=\"toc-level-4\">5.2.3.1 \uba74\uc5ed\uad00\ubb38 \uc5b5\uc81c\uc81c<\/li>\n<li class=\"toc-level-4\">5.2.3.2 CAR-T\/NK \uc138\ud3ec \uce58\ub8cc<\/li>\n<li class=\"toc-level-4\">5.2.3.3 \uc6a9\ud574\uc131 \ubc14\uc774\ub7ec\uc2a4<\/li>\n<li class=\"toc-level-3\">5.2.4 \uae30\uae30 \uae30\ubc18 \uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.2.5 \ubc29\uc0ac\uc120 \uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.2.6 \uc720\uc804\uc790 &amp; \uc138\ud3ec \uce58\ub8cc<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.3.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.3.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.3.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.3.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.3.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.3.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.3.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.3.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.3.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.3.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.3.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.3.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.3.4 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.3.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.3.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.3.4.3 \uae30\ud0c0 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.3.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.3.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.3.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.3.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uc0ac\uc6a9 \uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 F. Hoffmann-La Roche<\/li>\n<li class=\"toc-level-3\">6.3.2 Merck &amp; Co.<\/li>\n<li class=\"toc-level-3\">6.3.3 Pfizer<\/li>\n<li class=\"toc-level-3\">6.3.4 Novocure<\/li>\n<li class=\"toc-level-3\">6.3.5 Bristol-Myers Squibb<\/li>\n<li class=\"toc-level-3\">6.3.6 Amgen<\/li>\n<li class=\"toc-level-3\">6.3.7 AbbVie<\/li>\n<li class=\"toc-level-3\">6.3.8 AstraZeneca<\/li>\n<li class=\"toc-level-3\">6.3.9 Chimerix<\/li>\n<li class=\"toc-level-3\">6.3.10 DelMar Pharma<\/li>\n<li class=\"toc-level-3\">6.3.11 Sumitomo Heavy Industries<\/li>\n<li class=\"toc-level-3\">6.3.12 TAE Life Sciences<\/li>\n<li class=\"toc-level-3\">6.3.13 Bluebird Bio<\/li>\n<li class=\"toc-level-3\">6.3.14 Immunomic Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.15 Ono Pharma<\/li>\n<li class=\"toc-level-3\">6.3.16 GlaxoSmithKline<\/li>\n<li class=\"toc-level-3\">6.3.17 Novartis<\/li>\n<li class=\"toc-level-3\">6.3.18 Boehringer Ingelheim<\/li>\n<li class=\"toc-level-3\">6.3.19 Servier<\/li>\n<li class=\"toc-level-3\">6.3.20 Sun Pharma<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc131\uc778 \uc545\uc131 \uc2e0\uacbd\uad50\uc885 \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \ubd84\uc11d (2026-2031)<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc131\uc778 \uc545\uc131 \uc2e0\uacbd\uad50\uc885 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 \uaddc\ubaa8, \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc608\uce21\uc744 \uc9c8\ubcd1 \uc720\ud615, \uce58\ub8cc\ubc95, \uc9c0\uc5ed\ubcc4\ub85c \uc0c1\uc138\ud788 \ubd84\uc11d\ud569\ub2c8\ub2e4. 2025\ub144 31\uc5b5 7\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \ud3c9\uac00\ub41c \uc774 \uc2dc\uc7a5\uc740 2026\ub144 34\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144 50\uc5b5 8\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc608\uce21 \uae30\uac04(2026-2031) \ub3d9\uc548 \uc5f0\ud3c9\uade0 8.18%\uc758 \uacac\uace0\ud55c \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>1. \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc8fc\uc694 \ub3d9\ud5a5<\/p>\n<p>\uc2dc\uc7a5 \uc131\uc7a5\uc740 \ubbf8\uad6d \uc2dd\ud488\uc758\uc57d\uad6d(FDA)\uc758 \uc2e0\uc18d \uc2ec\uc0ac(fast-track) \ubc0f \ud601\uc2e0 \uce58\ub8cc\uc81c \uc9c0\uc815(breakthrough programs)\uc744 \ud1b5\ud55c \ud30c\uc774\ud504\ub77c\uc778 \ubaa8\uba58\ud140\uc5d0 \ud06c\uac8c \uae30\uc778\ud569\ub2c8\ub2e4. LP-184\uc640 \uac19\uc740 \ud601\uc2e0 \uc2e0\uc57d\uc758 \uc2ec\uc0ac \uae30\uac04 \ub2e8\ucd95\uacfc AI \uae30\ubc18 \uc9c4\ub2e8 \ub3c4\uad6c\uc758 \ubc1c\uc804\uc740 \uc885\uc591 \ud2b9\uc131 \ubd84\uc11d \ubc0f \uce58\ub8cc \ub9e4\uce6d\uc744 \uac1c\uc120\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubca4\ucc98 \uce90\ud53c\ud0c8\uc740 \uc815\ubc00 \uc758\ub8cc \ud50c\ub7ab\ud3fc\uc5d0 \uc9c0\uc18d\uc801\uc73c\ub85c \ud22c\uc790\ud558\uace0 \uc788\uc73c\uba70, \ub300\ud615 \uc81c\uc57d\uc0ac\ub4e4\uc740 \ud14c\ubaa8\uc878\ub85c\ub9c8\uc774\ub4dc(temozolomide) \ub0b4\uc131 \ubc0f \ud608\ub1cc\uc7a5\ubcbd(blood-brain-barrier) \uc804\ub2ec \ubb38\uc81c\ub97c \uadf9\ubcf5\ud558\uae30 \uc704\ud574 \ud45c\uc801 \uce58\ub8cc \ud3ec\ud2b8\ud3f4\ub9ac\uc624\ub97c \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed\uc801\uc73c\ub85c\ub294 \ubd81\ubbf8\uac00 \ubcf4\ud5d8 \uc9c0\uc6d0\uc744 \ud1b5\ud574 \uc0c1\uc5c5\uc801 \ud655\ub300\ub97c \uc8fc\ub3c4\ud558\uace0 \uc788\uc73c\ub098, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc758 \ubcd1\uc6d0 \ub124\ud2b8\uc6cc\ud06c \ud655\uc7a5\uacfc \uaddc\uc81c \uc870\ud654\uac00 \uc0c8\ub85c\uc6b4 \uc218\uc694\ub97c \ucd09\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc885\uc591 \uce58\ub8cc \uc804\uc7a5(TTFields)\uacfc \uac19\uc740 \uae30\uae30 \uae30\ubc18 \uce58\ub8cc\ubc95, \ubca0\ubc14\uc2dc\uc8fc\ub9d9(bevacizumab) \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \ucd9c\uc2dc, \uadf8\ub9ac\uace0 \ucd08\uae30 \uc5f0\uad6c\uc5d0\uc11c \uc591\ud638\ud55c \uc548\uc815 \uc9c8\ud658\uc728\uc744 \ubcf4\uc774\ub294 \uc138\ud3ec \uae30\ubc18 \uce58\ub8cc\ubc95\uc5d0\uc11c\ub3c4 \ubcd1\ud589\uc801\uc778 \uc131\uc7a5 \uae30\ud68c\uac00 \ub098\ud0c0\ub098\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>2. \ud575\uc2ec \ubcf4\uace0\uc11c \uc694\uc57d<\/p>\n<p>*   \uc9c8\ubcd1 \uc720\ud615\ubcc4: \uad50\ubaa8\uc138\ud3ec\uc885(Glioblastoma multiforme)\uc774 2025\ub144 \uc131\uc778 \uc545\uc131 \uc2e0\uacbd\uad50\uc885 \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 57.92%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc5ed\ud615\uc131 \ud76c\uc18c\ub3cc\uae30\uc544\uad50\uc885(Anaplastic oligodendroglioma)\uc740 2031\ub144\uae4c\uc9c0 9.12%\uc758 \uac00\uc7a5 \ube60\ub978 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uce58\ub8cc\ubc95\ubcc4: \ud654\ud559\uc694\ubc95\uc774 2025\ub144 \uc2dc\uc7a5 \uaddc\ubaa8\uc758 43.55%\ub97c \ucc28\uc9c0\ud588\uc73c\ub098, \uba74\uc5ed\uc694\ubc95\uc740 2026-2031\ub144 \ub3d9\uc548 12.41%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\ub85c \uc131\uc7a5\uc744 \uc8fc\ub3c4\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: \ubd81\ubbf8\uac00 2025\ub144 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 41.32%\ub97c \uc720\uc9c0\ud588\uc73c\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 2031\ub144\uae4c\uc9c0 11.55%\uc758 \uac00\uc7a5 \ube60\ub978 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>3. \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30\ub825<\/p>\n<p>3.1. \uc131\uc7a5 \ub3d9\uc778<\/p>\n<p>*   \uc545\uc131 \uc2e0\uacbd\uad50\uc885 \ubc1c\ubcd1\ub960 \uc99d\uac00: \uc5ed\ud559\uc801 \uc608\uce21\uc5d0 \ub530\ub974\uba74 \uc544\uc2dc\uc544 \uc9c0\uc5ed\uc758 \uc2e0\uacbd\uad50\uc885 \ubc1c\ubcd1 \uc0ac\ub840\ub294 2040\ub144\uae4c\uc9c0 39.3% \uc99d\uac00\ud558\uc5ec, \uc2dc\uc7a5\uc758 \uc911\uc2ec\uc774 \uc2e0\ud765 \uacbd\uc81c\uad6d\uc73c\ub85c \uc774\ub3d9\ud560 \uac83\uc785\ub2c8\ub2e4. \uac1c\uc120\ub41c \uc601\uc0c1 \uc9c4\ub2e8 \uc778\ud504\ub77c\ub294 \uc885\uc591\uc744 \uc870\uae30\uc5d0 \ubc1c\uacac\ud558\uace0 \uc788\uc73c\uba70, \uc80a\uc740 \uc544\uc2dc\uc544 \ucf54\ud638\ud2b8\uc758 \ub192\uc740 \uce58\ub8cc \ub0b4\uc131\uc740 \uc9c0\uc5ed\ubcc4 \uc784\uc0c1 \uc2dc\ud5d8 \ubc0f \ud504\ub85c\ud1a0\ucf5c \uc870\uc815\uc744 \uc7a5\ub824\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uacf5\uacf5 \ubd80\ubb38 R&#038;D \uc790\uae08 \uc9c0\uc6d0 \uc9c0\uc18d: \uc815\ubd80 \uc9c0\ucd9c\uc740 \ucd08\uae30 \ub2e8\uacc4\uc758 \uc704\ud5d8\uc744 \uc0c1\uc1c4\ud558\uba70 \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \uae30\uc5ec\ud569\ub2c8\ub2e4. \uce98\ub9ac\ud3ec\ub2c8\uc544 \uc7ac\uc0dd\uc758\ud559\uc5f0\uad6c\uc18c(CIRM)\ub294 UCSF\uc758 CAR-T \uad50\ubaa8\uc138\ud3ec\uc885 \ud504\ub85c\uadf8\ub7a8\uc5d0 1,100\ub9cc \ub2ec\ub7ec\ub97c \ud560\ub2f9\ud588\uc73c\uba70, \uc720\ub7fd\uc758 Horizon Europe \ubcf4\uc870\uae08\uc740 LEGATO \uc5f0\uad6c\ub97c \uc9c0\uc6d0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc2e0\uaddc \uae30\uae30\uc5d0 \ub300\ud55c \uc2e0\uc18d \uc2ec\uc0ac \ubc0f \ud601\uc2e0 \uce58\ub8cc\uc81c \uc9c0\uc815: FDA\ub294 \ub1cc \uc804\uc774 \uce58\ub8cc\ub97c \uc704\ud55c TTFields\uc5d0 \ud601\uc2e0 \uae30\uae30 \uc9c0\uc815\uc744 \ubd80\uc5ec\ud558\uace0 CAN-3110, TLX101-CDx \ub4f1\uc744 \uc2e0\uc18d \uc2ec\uc0ac\ud588\uc2b5\ub2c8\ub2e4. \uc720\ub7fd\uc758\uc57d\ud488\uccad(EMA)\uc758 Project Orbis \ucc38\uc5ec\ub294 \uc720\ub7fd-\ubbf8\uad6d \ucd9c\uc2dc \uaca9\ucc28\ub97c \ub2e8\ucd95\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   AI \uae30\ubc18 \uc870\uae30 \uc9c4\ub2e8 \ubc0f \uce58\ub8cc \uacc4\ud68d: \uba38\uc2e0\ub7ec\ub2dd \uc2dc\uc2a4\ud15c\uc740 \ubc29\uc0ac\uc120, \uc720\uc804\uccb4 \ubc0f \uc218\uc220 \uc911 \ub370\uc774\ud130\ub97c \uc2e4\ud589 \uac00\ub2a5\ud55c \uc9c0\uce68\uc73c\ub85c \ubcc0\ud658\ud569\ub2c8\ub2e4. FastGlioma \uc18c\ud504\ud2b8\uc6e8\uc5b4\ub294 \uc218\uc220 \uc911 \uc2e4\uc2dc\uac04 \uc885\uc591 \ubd84\ud560\uc744 \uc81c\uacf5\ud558\uba70, DeepGlioma \uc54c\uace0\ub9ac\uc998\uc740 IDH \ub3cc\uc5f0\ubcc0\uc774 \ud655\ub960 \uc810\uc218\ub97c \uc81c\uacf5\ud558\uc5ec \uc989\uac01\uc801\uc778 \uce58\ub8cc \uacb0\uc815\uc744 \uc9c0\uc6d0\ud569\ub2c8\ub2e4.<br \/>\n*   BNCT \ud50c\ub7ab\ud3fc\uc73c\ub85c\uc758 \ubca4\ucc98 \uce90\ud53c\ud0c8 \uc720\uc785 \uc99d\uac00: \ubd95\uc18c \uc911\uc131\uc790 \ud3ec\ud68d \uce58\ub8cc(BNCT) \ud50c\ub7ab\ud3fc\uc5d0 \ub300\ud55c \ubca4\ucc98 \uce90\ud53c\ud0c8 \ud22c\uc790\uac00 \uc804 \uc138\uacc4\uc801\uc73c\ub85c \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ubca0\ubc14\uc2dc\uc8fc\ub9d9 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\uc758 \uac00\uc6a9\uc131: \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\uc758 \ub4f1\uc7a5\uc740 \uac00\uaca9\uc5d0 \ubbfc\uac10\ud55c \uc2dc\uc7a5\uc5d0\uc11c \uce58\ub8cc \uc811\uadfc\uc131\uc744 \ub192\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>3.2. \uc81c\uc57d \uc694\uc778<\/p>\n<p>*   \ub0ae\uc740 \ud6c4\uae30 \uc784\uc0c1 \uc2dc\ud5d8 \uc131\uacf5\ub960: 3\uc0c1 \uad50\ubaa8\uc138\ud3ec\uc885 \ud504\ub85c\uadf8\ub7a8\uc758 \uc131\uacf5\ub960\uc740 5% \ubbf8\ub9cc\uc73c\ub85c, \ud22c\uc790\uc790 \uc2e0\ub8b0\ub97c \uc800\ud574\ud558\uace0 \uc790\ubcf8 \uc694\uad6c \uc0ac\ud56d\uc744 \uc99d\uac00\uc2dc\ud0b5\ub2c8\ub2e4. \uc774\ub294 \uae30\uc5c5\ub4e4\uc774 \uace0\uc704\ud5d8 \uc911\ucd94\uc2e0\uacbd\uacc4(CNS) \uc790\uc0b0\uacfc \uace0\ud615\uc554 \ud504\ub79c\ucc28\uc774\uc988 \uac04\uc758 \ud3ec\ud2b8\ud3f4\ub9ac\uc624 \ub2e4\uac01\ud654\ub97c \ubaa8\uc0c9\ud558\uac8c \ud569\ub2c8\ub2e4.<br \/>\n*   \ud14c\ubaa8\uc878\ub85c\ub9c8\uc774\ub4dc \ub0b4\uc131\uc758 \ube60\ub978 \ucd9c\ud604: \uce58\ub8cc \uc2dc\uc791 \ud6c4 6-12\uac1c\uc6d4 \uc774\ub0b4\uc5d0 MGMT \ud504\ub85c\ubaa8\ud130 \ud0c8\uba54\ud2f8\ud654\uc640 \uac19\uc740 \uc694\uc778\ub4e4\uc774 \ub9ce\uc740 \uad50\ubaa8\uc138\ud3ec\uc885 \ud658\uc790\uc5d0\uc11c \uc784\uc0c1\uc801 \uc7ac\ubc1c\uc744 \uc720\ubc1c\ud569\ub2c8\ub2e4. \uc774\ub85c \uc778\ud574 PARP \uc5b5\uc81c\uc81c \ubcd1\uc6a9 \uc694\ubc95 \ubc0f \uace0\ubd84\uc790 \ucea1\uc290\ud654 \ud14c\ubaa8\uc878\ub85c\ub9c8\uc774\ub4dc \uc81c\ud615\uacfc \uac19\uc740 \ub0b4\uc131 \uadf9\ubcf5 \uc804\ub7b5\uc5d0 \ub300\ud55c \ud22c\uc790\uac00 \uac00\uc18d\ud654\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ubd95\uc18c-10 \ub3d9\uc704\uc6d0\uc18c \uacf5\uae09\ub9dd \ubcd1\ubaa9 \ud604\uc0c1: BNCT \uac1c\ubc1c \uc9c0\uc5ed\uc5d0\uc11c \ubd95\uc18c-10 \ub3d9\uc704\uc6d0\uc18c \uacf5\uae09\ub9dd\uc758 \ubcd1\ubaa9 \ud604\uc0c1\uc774 \ubc1c\uc0dd\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc885\uc591\ud559 R&#038;D \uc790\ubcf8\uc758 \ub2e4\ub978 \ubd84\uc57c\ub85c\uc758 \uc804\ud658: \ubd81\ubbf8\uc640 \uc720\ub7fd\uc744 \uc911\uc2ec\uc73c\ub85c \uc885\uc591\ud559 R&#038;D \uc790\ubcf8\uc774 \ub2e4\ub978 \ubd84\uc57c\ub85c \uc804\ud658\ub418\ub294 \uacbd\ud5a5\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>4. \uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d<\/p>\n<p>4.1. \uc9c8\ubcd1 \uc720\ud615\ubcc4: \ubd84\uc790 \uc815\ubc00\ub3c4\uac00 \uce58\ub8cc \uc6b0\uc120\uc21c\uc704\ub97c \uc7ac\ud3b8<\/p>\n<p>\uad50\ubaa8\uc138\ud3ec\uc885\uc740 2025\ub144 \uc131\uc778 \uc545\uc131 \uc2e0\uacbd\uad50\uc885 \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 57.92%\ub97c \ucc28\uc9c0\ud558\uba70, \ud608\ub1cc\uc7a5\ubcbd \ud22c\uacfc \ud654\ud559 \ubc0f \uc801\uc751\ud615 \uc784\uc0c1 \uc2dc\ud5d8 \uc124\uacc4\uc5d0 \ub300\ud55c \uc2a4\ud3f0\uc11c\uc758 \ucd08\uc810\uc744 \uc774\ub04c\uc5c8\uc2b5\ub2c8\ub2e4. \ubcf4\ub77c\uc2dc\ub370\ub2d9(vorasidenib)\uacfc \uac19\uc740 IDH \ud45c\uc801 \ud601\uc2e0 \uce58\ub8cc\uc81c\uc758 \ub3c4\uc6c0\uc744 \ubc1b\uc740 \uc5ed\ud615\uc131 \ud76c\uc18c\ub3cc\uae30\uc544\uad50\uc885\uc740 2031\ub144\uae4c\uc9c0 9.12%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud558\uba70 \uc2dc\uc7a5 \uae30\uc5ec\ub3c4\ub97c \ub192\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubcf4\ub77c\uc2dc\ub370\ub2d9\uc740 \uc704\uc57d \ub300\ube44 11.1\uac1c\uc6d4\uc5d0 \ube44\ud574 27.7\uac1c\uc6d4\uc758 \ubb34\uc9c4\ud589 \uc0dd\uc874 \uae30\uac04(PFS)\uc744 \ub2ec\uc131\ud558\uba70 \uc720\uc804\uc790\ud615 \uae30\ubc18 \uc124\uacc4\uc758 \uc6b0\uc218\uc131\uc744 \uc785\uc99d\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>4.2. \uce58\ub8cc\ubc95\ubcc4: \ucc28\uc138\ub300 \uce58\ub8cc\ubc95\uc758 \uacbd\uc7c1 \uc2ec\ud654<\/p>\n<p>\ud654\ud559\uc694\ubc95\uc740 2025\ub144 \uc131\uc778 \uc545\uc131 \uc2e0\uacbd\uad50\uc885 \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uaddc\ubaa8\uc758 43.55%\ub97c \uc720\uc9c0\ud558\uba70, \uc0c8\ub85c \uc9c4\ub2e8\ub41c \ud658\uc790\uc5d0\uac8c \ud14c\ubaa8\uc878\ub85c\ub9c8\uc774\ub4dc\uac00 \uad11\ubc94\uc704\ud558\uac8c \uc0ac\uc6a9\ub418\uace0 \uc788\uc74c\uc744 \ubc18\uc601\ud569\ub2c8\ub2e4. \ucd08\uae30 CAR-T \ubc0f PD-1 \ubcd1\uc6a9 \uc694\ubc95\uc758 \uc2e0\ud638\uc5d0 \ud798\uc785\uc5b4 \uba74\uc5ed\uc694\ubc95\uc740 12.41%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\ub85c \ud655\uc7a5\ub418\uace0 \uc788\uc73c\uba70, \ub4f1\ub85d \uc784\uc0c1 \uc2dc\ud5d8\uc774 \uc131\uc219\ub418\uba74 \uc0c1\ub2f9\ud55c \uc810\uc720\uc728\uc744 \ud655\ubcf4\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. TTFields\uc640 \uac19\uc740 \uae30\uae30 \uae30\ubc18 \uc811\uadfc\ubc95\uc740 \uc801\uc751\uc99d \ud655\ub300 \ubc0f \ubcf4\ud5d8 \uc801\uc6a9\uc744 \ud1b5\ud574 \uc9c0\uc18d\uc801\uc73c\ub85c \uc131\uc7a5\ud558\uace0 \uc788\uc73c\uba70, \uc720\uc804\uc790 \ubc0f \uc138\ud3ec \uce58\ub8cc\ubc95\uc740 \uc791\uc740 \uae30\ubc18\uc5d0\uc11c \ube60\ub974\uac8c \ubc1c\uc804\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>5. \uc9c0\uc5ed \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8: 2025\ub144 \uc131\uc778 \uc545\uc131 \uc2e0\uacbd\uad50\uc885 \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uaddc\ubaa8\uc758 41.32%\ub97c \ucc28\uc9c0\ud558\uba70, \uac15\ub825\ud55c \ubcf4\ud5d8 \uc81c\ub3c4, NCI \uc9c0\uc815 \uc784\uc0c1 \uc2dc\ud5d8 \ub124\ud2b8\uc6cc\ud06c \ubc0f \ub192\uc740 \uc9c4\ub2e8\uc728\uc5d0 \ud798\uc785\uc5b4 \uc2dc\uc7a5\uc744 \uc120\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubbf8\uad6d\uc740 \uc2e0\uc18d \uc2ec\uc0ac \uc9c0\uc815\uc744 \ud1b5\ud574 \ubcf4\ub77c\uc2dc\ub370\ub2d9\uacfc \uac19\uc740 \uc81c\ud488\uc774 1\ub144 \uc774\ub0b4\uc5d0 \uc2b9\uc778\ub420 \uc218 \uc788\ub3c4\ub85d \ud569\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: 11.55%\uc758 \uac00\uc7a5 \ube60\ub978 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \ubcf4\uc774\ub294 \uc9c0\uc5ed\uc73c\ub85c, \ud604\ub300\uc801\uc778 \ubc29\uc0ac\uc120 \uce58\ub8cc \uc2dc\uc124\uc744 \ud655\ucda9\ud558\uace0 \uc911\uad6d, \uc77c\ubcf8, \ud55c\uad6d \uc13c\ud130\uc758 \uae00\ub85c\ubc8c \ud504\ub85c\ud1a0\ucf5c \ucc38\uc5ec\ub97c \uac00\uc18d\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubca0\uc774\uc9d5\uacfc \uc0c1\ud558\uc774\uc758 \ub300\ud615 3\ucc28 \ubcd1\uc6d0\uc5d0\uc11c \ubcf4\uace0\ub41c \uc6b0\uc218\ud55c \uc0dd\uc874 \uc9c0\ud45c\ub294 \ud504\ub85c\ud1a0\ucf5c \ucc28\uc774\ub97c \ud574\ub3c5\ud558\uae30 \uc704\ud55c \ube44\uad50 \ud6a8\uacfc \uc5f0\uad6c \ud611\ub825\uc744 \ucd09\ubc1c\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: EMA\uc758 Project Orbis\uac00 \uc2dc\uc7a5 \uc9c4\uc785 \uaca9\ucc28\ub97c \ub2e8\ucd95\uc2dc\ud0a4\uba74\uc11c \uc548\uc815\uc801\uc778 \ubaa8\uba58\ud140\uc744 \ubcf4\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub3c5\uc77c, \ud504\ub791\uc2a4, \uc601\uad6d\uc774 \uc784\uc0c1 \uc2dc\ud5d8 \uc2dc\uc791\uc744 \uc8fc\ub3c4\ud558\uba70, Horizon Europe \ubcf4\uc870\uae08\uc740 LEGATO\uc640 \uac19\uc740 \ub2e4\uad6d\uc801 \ub370\uc774\ud130\uc14b\uc744 \uc9c0\uc6d0\ud558\uc5ec NICE \ubc0f G-BA \uacb0\uc815\uc5d0 \uc9c1\uc811\uc801\uc778 \uc601\ud5a5\uc744 \ubbf8 \ubbf8\uce58\ub294 \uc5f0\uad6c\uc790 \uc8fc\ub3c4 \uc99d\uac70 \uc0dd\uc131\uc744 \uac15\ud654\ud569\ub2c8\ub2e4.<\/p>\n<p>6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\uc131\uc778 \uc545\uc131 \uc2e0\uacbd\uad50\uc885 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 \uc911\uac04 \uc815\ub3c4\uc758 \uc9d1\uc911\ub3c4\ub97c \ubcf4\uc774\uba70, \uc0c1\uc704 \uae30\uc5c5\ub4e4\uc774 \uc0c1\ub2f9\ud55c \uc218\uc775\uc744 \ud1b5\uc81c\ud558\uc9c0\ub9cc \ud2c8\uc0c8 \ubd84\uc790 \ud45c\uc801\uc744 \ud65c\uc6a9\ud558\ub294 \ubbfc\ucca9\ud55c \ubc14\uc774\uc624\ud14d\uc744 \uc704\ud55c \uc5ec\uc9c0\ub97c \ub0a8\uaca8\ub450\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub300\ud615 \uc81c\uc57d\uc0ac\ub4e4\uc740 \uc778\uc218\ud569\ubcd1(M&#038;A)\uc744 \ud1b5\ud574 \ud30c\uc774\ud504\ub77c\uc778\uc744 \uac15\ud654\ud558\uace0 \uc788\uc73c\uba70, Jazz Pharmaceuticals\uc758 Chimerix \uc778\uc218(dordaviprone)\ub294 H3 K27M \ub3cc\uc5f0\ubcc0\uc774 \uc790\uc0b0\uc5d0 \ub300\ud55c \uad00\uc2ec\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. Novocure\ub294 \uc131\uc778 \ubc0f \uc18c\uc544 \uc801\uc751\uc99d \ubaa8\ub450\uc5d0\uc11c TTFields\uc758 \uc120\ub450 \uc8fc\uc790 \uc9c0\uc704\ub97c \uc720\uc9c0\ud558\uba70 MSD\uc640 \ud611\ub825\ud558\uc5ec \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c \uc2dc\ub108\uc9c0\ub97c \ud0d0\uc0c9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ud608\ub1cc\uc7a5\ubcbd \uc804\ub2ec \ud654\ud559\uc774 \ubcf4\ud3b8\uc801\uc778 \ub09c\uad00\uc73c\ub85c \ub0a8\uc544\uc788\uc74c\uc5d0 \ub530\ub77c \uc804\ub7b5\uc801 \uc81c\ud734\uac00 \ud655\uc0b0\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub9ac\ud3ec\uc19c, \uace0\ubd84\uc790 \uc811\ud569\uccb4 \ub610\ub294 \uc9d1\uc911 \ucd08\uc74c\ud30c \ud50c\ub7ab\ud3fc\uc744 \ubcf4\uc720\ud55c \ubc14\uc774\uc624\ud14d\uc740 \uc804\uccb4 \uac1c\ubc1c \uc8fc\uae30\ub97c \ucd94\uc9c4\ud558\uae30\ubcf4\ub2e4\ub294 \uae30\uc220 \ub77c\uc774\uc120\uc2a4\ub97c \uc120\ud638\ud569\ub2c8\ub2e4. CAR-T \uc5d4\uc9c0\ub2c8\uc5b4\ub9c1 \ubc0f \uc2e0\ud56d\uc6d0 \uac1c\uc778\ud654\uc5d0 \ub300\ud55c \uc9c0\uc801 \uc7ac\uc0b0\uad8c \uacbd\uc7c1\uc774 \uc2ec\ud654\ub418\uba74\uc11c \uc804 \uc138\uacc4\uc801\uc778 \uc0c1\ud638 \ucc28\ub2e8\uc744 \ud53c\ud558\uae30 \uc704\ud55c \uad50\ucc28 \ub77c\uc774\uc120\uc2a4\uac00 \ucd09\uc9c4\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uac00\uaca9 \ucc45\uc815 \uc5ed\ud559\uc740 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\uac00 \uae30\uc874 \ub2e8\uc77c\ud074\ub860\ud56d\uccb4\uc5d0 \uc555\ub825\uc744 \uac00\ud558\ub294 \ubc18\uba74, \ud76c\uadc0\uc758\uc57d\ud488 \ub3c5\uc810\uad8c\uc740 \ub3cc\uc5f0\ubcc0\uc774 \ud2b9\uc774\uc801 \uce58\ub8cc\uc81c\uc758 \ud504\ub9ac\ubbf8\uc5c4 \ud3ec\uc9c0\uc154\ub2dd\uc744 \uc720\uc9c0\ud558\uba74\uc11c \uc9c4\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\uc5d0 \ub530\ub77c \uae30\uc5c5\ub4e4\uc740 \uc2e4\uc81c \uacb0\uacfc\uc5d0 \uc9c0\ubd88\uc744 \uc5f0\uacc4\ud558\ub294 \uac00\uce58 \uae30\ubc18 \ubcf4\uc0c1 \ubaa8\ub378\uc744 \ub3c4\uc785\ud558\uc5ec \uacbd\uc81c\uc801 \uc778\uc13c\ud2f0\ube0c\ub97c \uc784\uc0c1 \uacb0\uacfc\uc640 \uc77c\uce58\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>7. \uc8fc\uc694 \uae30\uc5c5<\/p>\n<p>*   Merck &#038; Co. Inc.<br \/>\n*   Bristol-Myers Squibb Company<br \/>\n*   F. Hoffmann-La Roche Ltd<br \/>\n*   Bio-Rad Laboratories<br \/>\n*   Azurity Pharmaceuticals, Inc.<\/p>\n<p>8. \ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5<\/p>\n<p>*   2025\ub144 4\uc6d4: FDA\ub294 Biocon Biologics\uc758 Jobevne (bevacizumab-nwgd) \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\ub97c \uc7ac\ubc1c\uc131 \uad50\ubaa8\uc138\ud3ec\uc885\uc744 \ud3ec\ud568\ud55c \uc5ec\ub7ec \uc554 \uc801\uc751\uc99d\uc5d0 \ub300\ud574 \uc2b9\uc778\ud558\uc5ec, \uc800\ub834\ud55c \uce58\ub8cc \uc811\uadfc\uc131\uc744 \ud655\ub300\ud558\uace0 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uacbd\uc7c1\uc744 \uc2ec\ud654\uc2dc\ucf30\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 2\uc6d4: FDA\ub294 H3K27M \ub3cc\uc5f0\ubcc0\uc774 \ubbf8\ub9cc\uc131 \uc2e0\uacbd\uad50\uc885 \uce58\ub8cc\uc81c dordaviprone\uc5d0 \ub300\ud574 \uc6b0\uc120 \uc2ec\uc0ac\ub97c \ubd80\uc5ec\ud588\uc73c\uba70, PDUFA \ub0a0\uc9dc\ub294 2025\ub144 8\uc6d4 18\uc77c\ub85c \uc774 \ud76c\uadc0 \uc18c\uc544 \uc801\uc751\uc99d\uc5d0 \ub300\ud55c \uc7a0\uc7ac\uc801\uc778 \uccab \uc2b9\uc778\uc744 \uc758\ubbf8\ud569\ub2c8\ub2e4.<br \/>\n*   2024\ub144 8\uc6d4: FDA\ub294 Servier\uc758 vorasidenib (Voranigo)\ub97c 2\ub4f1\uae09 IDH \ub3cc\uc5f0\ubcc0\uc774 \uc2e0\uacbd\uad50\uc885\uc5d0 \ub300\ud55c \ucd5c\ucd08\uc758 \ud45c\uc801 \uce58\ub8cc\uc81c\ub85c \uc2b9\uc778\ud558\uc5ec, \ubd84\uc790\uc801\uc73c\ub85c \uc815\uc758\ub41c \ud658\uc790 \uc9d1\ub2e8\uc744 \uc704\ud55c \uc0c8\ub85c\uc6b4 \uce58\ub8cc \ud45c\uc900\uc744 \ud655\ub9bd\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc131\uc778 \uc545\uc131 \uc2e0\uacbd\uad50\uc885 \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc545\uc131 \uc2e0\uacbd\uad50\uc885\uc740 \uac00\uc7a5 \ud754\ud55c \uc6d0\ubc1c\uc131 \ub1cc\uc885\uc591 \uc544\ud615\uc73c\ub85c, \uacf5\uaca9\uc801\uc774\uace0 \uce68\uc2b5\uc801\uc774\uba70 \uc2e0\uacbd\ud559\uc801\uc73c\ub85c \ud30c\uad34\uc801\uc778 \ud2b9\uc131\uc744 \uac00\uc9c4 \uc778\uac04 \uc554 \uc911 \uac00\uc7a5 \uce58\uba85\uc801\uc778 \uc720\ud615\uc73c\ub85c \uac04\uc8fc\ub429\ub2c8\ub2e4.<\/p>\n<p>2026\ub144 \uc804 \uc138\uacc4 \uc131\uc778 \uc545\uc131 \uc2e0\uacbd\uad50\uc885 \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uaddc\ubaa8\ub294 34\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \ub2ec\ud558\uba70, 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 8.18%\uc758 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud558\uc5ec 2031\ub144\uc5d0\ub294 50\uc5b5 8\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\ub85c \ud655\ub300\ub420 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc73c\ub85c\ub294 \uc545\uc131 \uc2e0\uacbd\uad50\uc885 \ubc1c\ubcd1\ub960 \uc99d\uac00, \uacf5\uacf5 \ubd80\ubb38\uc758 \uc9c0\uc18d\uc801\uc778 R&#038;D \uc790\uae08 \uc9c0\uc6d0, \uc2e0\uaddc \uae30\uae30\uc5d0 \ub300\ud55c \uc2e0\uc18d \uc2ec\uc0ac \ubc0f \ud601\uc2e0 \uc758\ub8cc\uae30\uae30 \uc9c0\uc815, AI \uae30\ubc18 \uc870\uae30 \uc9c4\ub2e8 \ubc0f \uce58\ub8cc \uacc4\ud68d \ubc1c\uc804, BNCT(\ubd95\uc18c \uc911\uc131\uc790 \ud3ec\ud68d \uce58\ub8cc) \ud50c\ub7ab\ud3fc\uc5d0 \ub300\ud55c \ubca4\ucc98 \uce90\ud53c\ud0c8 \ud22c\uc790 \uae09\uc99d, \uadf8\ub9ac\uace0 \ubca0\ubc14\uc2dc\uc8fc\ub9d9 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\uc758 \uac00\uc6a9\uc131 \ud655\ub300 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubc18\uba74, \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c\ub294 \ub0ae\uc740 \ud6c4\uae30 \uc784\uc0c1\uc2dc\ud5d8 \uc131\uacf5\ub960, \ud14c\ubaa8\uc878\ub85c\ub9c8\uc774\ub4dc(Temozolomide) \ub0b4\uc131\uc758 \ube60\ub978 \ubc1c\ud604, \ubd95\uc18c-10 \ub3d9\uc704\uc6d0\uc18c \uacf5\uae09\ub9dd \ubcd1\ubaa9 \ud604\uc0c1, \uadf8\ub9ac\uace0 \ubc1c\uc0dd\ub960\uc774 \ub192\uc740 \ub2e4\ub978 \uc885\uc591\uc73c\ub85c\uc758 \ud56d\uc554 R&#038;D \uc790\ubcf8 \uc804\ud658 \ub4f1\uc774 \uc9c0\uc801\ub429\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc9c8\ubcd1 \uc720\ud615\ubcc4(\uad50\ubaa8\uc138\ud3ec\uc885, \uc5ed\ud615\uc131 \uc131\uc0c1\uc138\ud3ec\uc885, \uc5ed\ud615\uc131 \ud76c\uc18c\ub3cc\uae30\uc544\uad50\uc885, \uc5ed\ud615\uc131 \ud76c\uc18c\uc131\uc0c1\uc138\ud3ec\uc885 \ubc0f \uae30\ud0c0 \uace0\ub4f1\uae09 \uc2e0\uacbd\uad50\uc885), \uce58\ub8cc\ubc95\ubcc4(\ud654\ud559\uc694\ubc95, \ud45c\uc801 \uce58\ub8cc, \uba74\uc5ed\uc694\ubc95, \uae30\uae30 \uae30\ubc18 \uce58\ub8cc, \ubc29\uc0ac\uc120 \uce58\ub8cc, \uc720\uc804\uc790 \ubc0f \uc138\ud3ec \uce58\ub8cc), \uadf8\ub9ac\uace0 \uc9c0\uc5ed\ubcc4(\ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8)\ub85c \uc2dc\uc7a5\uc744 \uc138\ubd84\ud654\ud558\uc5ec \ubd84\uc11d\ud569\ub2c8\ub2e4. \uce58\ub8cc\ubc95 \uc138\ubd80 \ubd84\ub958\uc5d0\ub294 \ud654\ud559\uc694\ubc95(\ud14c\ubaa8\uc878\ub85c\ub9c8\uc774\ub4dc, \ub85c\ubb34\uc2a4\ud2f4, \uce74\ub974\ubb34\uc2a4\ud2f4, \ubca0\ubc14\uc2dc\uc8fc\ub9d9 \ub4f1), \ud45c\uc801 \uce58\ub8cc(EGFR, VEGF\/VEGFR, IDH \uc5b5\uc81c\uc81c), \uba74\uc5ed\uc694\ubc95(\uba74\uc5ed\uad00\ubb38 \uc5b5\uc81c\uc81c, CAR-T\/NK \uc138\ud3ec \uce58\ub8cc, \uc6a9\ud574\uc131 \ubc14\uc774\ub7ec\uc2a4) \ub4f1\uc774 \ud3ec\ud568\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \ubd84\uc11d \uacb0\uacfc\uc5d0 \ub530\ub974\uba74, \ud604\uc7ac \uac00\uc7a5 \ub192\uc740 \ub9e4\ucd9c\uc744 \uae30\ub85d\ud558\ub294 \uce58\ub8cc\ubc95\uc740 \ud14c\ubaa8\uc878\ub85c\ub9c8\uc774\ub4dc\uc758 \uad11\ubc94\uc704\ud55c \uc0ac\uc6a9\uc5d0 \ud798\uc785\uc5b4 \ud654\ud559\uc694\ubc95\uc774 43.55%\uc758 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc9c8\ubcd1 \ud558\uc704 \uc720\ud615\uc740 \ubcf4\ub77c\uc2dc\ub370\ub2d9(vorasidenib)\uacfc \uac19\uc740 IDH \ud45c\uc801 \uce58\ub8cc\uc81c\uc758 \ubc1c\uc804\uc73c\ub85c \uc5f0\ud3c9\uade0 9.12% \uc131\uc7a5\ud558\ub294 \uc5ed\ud615\uc131 \ud76c\uc18c\ub3cc\uae30\uc544\uad50\uc885\uc785\ub2c8\ub2e4. \uce58\ub8cc\uc81c \ucc44\ud0dd\uc774 \uac00\uc7a5 \ube60\ub974\uac8c \uc99d\uac00\ud558\ub294 \uc9c0\uc5ed\uc740 \uc784\uc0c1 \uc778\ud504\ub77c \uac1c\uc120 \ubc0f \uaddc\uc81c \uc870\ud654\uc5d0 \ud798\uc785\uc5b4 \uc5f0\ud3c9\uade0 11.55% \uc131\uc7a5\ud558\ub294 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc785\ub2c8\ub2e4. \uba74\uc5ed\uc694\ubc95 \uc635\uc158 \ucc44\ud0dd\uc744 \uac00\uc18d\ud654\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc740 \ucd08\uae30 \ub2e8\uacc4 CAR-T \uc5f0\uad6c\uc5d0\uc11c 50%\uc758 \uc548\uc815 \ubcd1\ubcc0\uc728\uc744 \ubcf4\uc5ec \uc784\uc0c1\uc758\ub4e4\uc774 \uce58\ub8cc \uacc4\ud68d\uc5d0 \uba74\uc5ed\uc694\ubc95\uc744 \ucd94\uac00\ud558\ub3c4\ub85d \uc7a5\ub824\ud558\uace0 \uc788\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4.<\/p>\n<p>\ubcf4\uace0\uc11c\ub294 \ub610\ud55c \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d, F. Hoffmann-La Roche, Merck &#038; Co., Pfizer, Novocure \ub4f1 \uc8fc\uc694 20\uac1c \uae30\uc5c5\uc758 \ud504\ub85c\ud544\uc744 \ud3ec\ud568\ud55c \uacbd\uc7c1 \ud658\uacbd\uc744 \uc0c1\uc138\ud788 \ub2e4\ub8e8\uba70, \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd\uc5d0 \ub300\ud55c \ud3c9\uac00\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-46001","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/46001"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=46001"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/46001\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=46001"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=46001"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=46001"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}